Vytrus Biotech (XMAD:VYT) Total Current Assets : €3.53 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vytrus Biotech Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Vytrus Biotech's total current assets for the quarter that ended in Jun. 2024 was €3.53 Mil.

Vytrus Biotech Total Current Assets Historical Data

The historical data trend for Vytrus Biotech's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vytrus Biotech Total Current Assets Chart

Vytrus Biotech Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

1.16

1.54

1.82

1.68

2.45

Vytrus Biotech Semi-Annual Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Current Assets	Get a 7-Day Free Trial					1.86	1.68	2.51	2.45	3.53

Vytrus Biotech Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Vytrus Biotech's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	1.105	+	0.781	+	0.551	+	0.015
	=	2.45

Vytrus Biotech's Total Current Assets for the quarter that ended in Jun. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	2.219	+	0.779	+	0.506	+	0.029
	=	3.53

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Vytrus Biotech (XMAD:VYT) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Vytrus Biotech's Liquidation Value for the quarter that ended in Jun. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2.219	-	3.838	+	0.75 * 0.603	+	0.5 * 0.506
=	-0.91

Vytrus Biotech Total Current Assets Related Terms

Thank you for viewing the detailed overview of Vytrus Biotech's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vytrus Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vytrus Biotech SA (XMAD:VYT) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sant Gaieta 121, 2nd, Terrassa, Barcelona, ESP, 08221

Website

https://www.vytrus.com

Vytrus Biotech SA develops natural active ingredients on an industrial scale. The natural actives offered by the company include Nectaria Lithops, Olea Vitae, Turmeric zen, Capilia Longa, Qura Noni.

Vytrus Biotech Headlines

No Headlines